GetTopicDetailResponse(id=a7901103555e, topicName=3期研究, introduction=3期研究, content=圍手術期 肌層浸潤性膀胱癌 3期研究, image=null, comments=0, allHits=946, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Mon Jan 22 09:22:37 CST 2024, time=2024-01-22, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=486118, tagList=[TagDto(tagId=486118, tagName=3期研究)], ipAttribution=上海, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2183117, encodeId=ee98218311eaf, content=<a href='/topic/show?id=1cf64063952' target=_blank style='color:#2F92EE;'>#圍手術期#</a> <a href='/topic/show?id=41218091691' target=_blank style='color:#2F92EE;'>#肌層浸潤性膀胱癌#</a> <a href='/topic/show?id=a7901103555e' target=_blank style='color:#2F92EE;'>#3期研究#</a>, objectTitle=Lancet Oncol：圍手術期大劑量甲氨蝶呤、長春堿、阿霉素和順鉑治療肌層浸潤性膀胱癌（VESPER）：一項開放標簽、隨機、3期研究中5年的生存終點, objectType=article, longId=810429, objectId=cf69810429c7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240121/1705849215237_6145188.png, objectUrl=/article/show_article.do?id=cf69810429c7, replyNumber=0, likeNumber=175, createdTime=2024-01-22, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=cf69810429c7, moduleTitle=Lancet Oncol：圍手術期大劑量甲氨蝶呤、長春堿、阿霉素和順鉑治療肌層浸潤性膀胱癌（VESPER）：一項開放標簽、隨機、3期研究中5年的生存終點, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=cf69810429c7)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-01-22發(fā)表于上海
